Range
519.98 - 530.26
Vol / Avg.
623.1K/822.7K
Div / Yield
-
52 Wk
441 - 664.64
Mkt Cap
56B
Payout Ratio
-
Open
529.28
P/E
14.94
EPS
10.58
Shares
106.5M
Outstanding
106.5M
Total Float
-
load more
Sector: Health Care.Industry: Biotechnology
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products including: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-04
REV
Q1 2021Est.ActualSurprise
EPS9.0309.890 0.8600
REV2.560B2.529B-31.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
REGNRegeneron Pharmaceuticals-1.22%56B

Regeneron Pharmaceuticals Frequently Asked Questions

Q

How do I buy Regeneron Pharmaceuticals (REGN) stock?

A

You can purchase shares of Regeneron Pharmaceuticals (NASDAQ: REGN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Regeneron Pharmaceuticals's (REGN) competitors?

Q

What is the target price for Regeneron Pharmaceuticals (REGN) stock?

A

The latest price target for Regeneron Pharmaceuticals (NASDAQ: REGN) was reported by Morgan Stanley on May 7, 2021. The analyst firm set a price target for 495.00 expecting REGN to fall to within 12 months (a possible -5.81% downside). 34 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Regeneron Pharmaceuticals (REGN)?

A

The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $525.55 last updated Fri Jun 11 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Regeneron Pharmaceuticals (REGN) pay a dividend?

A

There are no upcoming dividends for Regeneron Pharmaceuticals.

Q

When is Regeneron Pharmaceuticals (NASDAQ:REGN) reporting earnings?

A
Regeneron Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 4, 2021.
Q

Is Regeneron Pharmaceuticals (REGN) going to split?

A

There is no upcoming split for Regeneron Pharmaceuticals.

Q

What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?

A

Regeneron Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.